HSD17B13-IN-9
HSD17B13-IN-9 (252) is a 17β-Hydroxysteroid dehydrogenases (HSD17B13) inhibitor, with an IC50 of 0.01 μM for 50 nM HSD17B13. Used in NAFLD (Nonalcoholic fatty liver diseases) research[1].
Product Specifications
CAS Number
2576690-78-1
UNSPSC
12352005
Target
17β-HSD
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/hsd17b13-in-9.html
Purity
99.92
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
CC1=CC=C2C(SC3=C(C2NC(C4=CC=C(NC4=O)C(F)(F)F)=O)C=CC(C)=C3)=C1
Molecular Formula
C22H17F3N2O2S
Molecular Weight
430.44
References & Citations
[1]Joseph Vacca, et al. Modulators of hsd17b13 and methods of use thereof. Patent WO2021003295.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light, stored under nitrogen)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LY401250 100 µg
APRIL (TNFSF13) (NM_003808) Human Over-expression Lysate
Sign In for Pricing
View Details 
TRC-D759997-2.5MG 2.5 mg
Difluorophenyl-3-(5-fluoropyrimidin-4-yl)-1-(1,2,4-triazol-1-yl)butan-2-ol-d3
Sign In for Pricing
View Details 
